Standardizing Right Hemicolectomy for Colon Cancer

Launched by AMSTERDAM UMC, LOCATION VUMC · May 13, 2021

Keywords

ClinConnect Summary

This clinical trial is focused on improving the surgical technique used for laparoscopic right hemicolectomy, which is a common surgery for treating right-sided colon cancer. The goal is to standardize how this surgery is performed to ensure that all patients receive the best possible care, regardless of where they have the surgery done. Researchers believe that by having a consistent approach, they can enhance the quality of surgery and ultimately improve patient outcomes, such as reducing complications after the operation.

To be eligible for this trial, participants should be adults over 18 years old who are scheduled for a laparoscopic right hemicolectomy due to colon cancer that is classified as stage 1 to 3. They should not have had previous major abdominal surgery or certain other health conditions. If you choose to participate, you can expect to undergo the standard surgical procedure while contributing to important research aimed at enhancing surgical practices. The trial will carefully monitor participants for any complications within 30 days after surgery, which will help in assessing how well the standardized technique works.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Planned laparoscopic (extended) right hemicolectomy for colon cancer of the caecum, ascending colon or hepatic flexure;
• • Age above 18 years;
• • cTNM stage 1-3 (CT-staged);
• • No prior midline or transverse laparotomy;
• • ASA1-3;
• • No immune modulating medication.
• Exclusion Criteria:
• • cT4b;
• • Perforated disease;
• • Acute obstruction;
• • Emergency operation;
• • Appendiceal cancer;
• • Other primary malignancy treated within 5 years from diagnosis of colon cancer, except for curatively treated prostate, breast, skin and cervical cancer.